- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03155321
SAGES Safe Cholecystectomy Program in Polish Reality - Awareness, Implementation and Opinion on Usefulness
The Assessment of Awareness and Implementation of the SAGES Safe Cholecystectomy Program Among Polish Surgeons, as Well as Their Opinion on the Usefulness of the SAGES Safe Cholecystectomy Rules: Increasing the Safety of Cholecystectomy by Popularising the SAGES Safe Cholecystectomy Program
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The study is based on an anonymous questionnaire that is distributed among polish surgeons across the country. The questionnaire focuses on the demographic data of the surgeon, their experience in years, a few questions regarding their experience in the field of cholecystectomy surgery and questions about whether or not they are familiar with the SAGES Safe Cholecystectomy Program, Teaching Program for the Culture of Safety in Cholecystectomy, as well as Updated Tokyo Guidelines for the management of acute cholangitis and cholecystitis. The questionnaire is available as an appendix. It is then followed by the list of all the Rules of SAGES Safe Cholecystectomy Program with questions about the usefulness of each of the rule, evaluated in form of a 10-point numeric scale (0 - completely useless, 9 - critical).
The collected data will be subject to statistical analysis, the result of which will form the base for creating the Polish Program for Safe Cholecystectomy that will serve to increase the safety of this very common surgical procedure.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Małopolska
-
Kraków, Małopolska, Poland, 31-008
- Jagiellonian University Medical College
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- general surgery specialist or resident registered in Polish National Doctors' Registry
- filled questionnaire on SAGES Safe Cholecystectomy Program
Exclusion Criteria:
- questionnaire not filled properly, missing answers
- declaration of not being either general surgeon specialist of general surgery resident in Poland
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Polish General Surgeons
The group is formed by active polish general surgeons, both specialists and in training
|
No intervention is planned
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Mean usefulness score of each SAGES Safe Cholecystectomy Rule
Time Frame: 01.04.2017 - 31.12.2017
|
The usefulness of each rule will be assessed by the participants on a 10-point numeric scale (0 - useless, 9 - critical) which will be part of the questionnaire
|
01.04.2017 - 31.12.2017
|
Collaborators and Investigators
Sponsor
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- K/ZDS/005504
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cholecystectomy, Laparoscopic
-
Wake Forest University Health SciencesAmerican College of SurgeonsCompletedCholecystectomy, Laparoscopic | Appendectomy, Laparoscopic | Cholecystectomy, RoboticUnited States
-
Clinical Research Centre, MalaysiaCompletedComplication Laparoscopic Cholecystectomy | Conversion Laparoscopic to Open CholecystectomyMalaysia
-
Intuitive SurgicalCompletedLaparoscopic Cholecystectomy | Robotic-assisted CholecystectomyUnited States
-
Assiut UniversityNot yet recruiting
-
IHU StrasbourgScialytics SASRecruitingCholecystectomy, LaparoscopicFrance
-
Assiut UniversityNot yet recruiting
-
Mohamed Bakr Mohamed AhmedNot yet recruitingLaparoscopic Cholecystectomy
-
Istanbul University - CerrahpasaActive, not recruitingCholecystectomy, LaparoscopicTurkey (Türkiye)
-
Ulas AdayCompletedLaparoscopic CholecystectomyTurkey (Türkiye)
-
Mansoura UniversityCompletedLaparoscopic CholecystectomyEgypt
Clinical Trials on It's an observational study - no intervention is planned
-
Bnai Zion Medical CenterNot yet recruitingIron Adverse Reaction | Anemia Complicating PregnancyIsrael
-
Olive Fertility CentreThermo Fisher Scientific, Inc; Sequence46RecruitingInfertility | AneuploidyCanada
-
Chisquares IncorporatedNot yet recruitingCOVID-19 | Burnout, Professional | Patient Engagement | Artificial Intelligence | Substance Use Disorders | Mental Health Issue | Climate Change | Preventable Disease, Vaccine | Emerging Infectious Disease | Online Education
-
Institute of Liver and Biliary Sciences, IndiaNot yet recruitingAcute-On-Chronic Liver FailureIndia
-
Riitta VeijolaTurku University Hospital; Juvenile Diabetes Research Foundation; University... and other collaboratorsRecruiting
-
Duke UniversityCompletedSuspicious Skin Lesion(s) Requiring a BiopsyUnited States
-
Walter Reed National Military Medical CenterJohns Hopkins UniversityRecruitingTraumatic Brain Injury | Vascular Dementia | Cognitive DeclineUnited States
-
Children's Hospital of Fudan UniversityCompletedProlonged Mechanical VentilationChina
-
Ohio State UniversityAbbVieCompleted
-
Zenalux Biomedical, Inc.National Cancer Institute (NCI); Duke UniversityUnknownSquamous Cell CarcinomaUnited States